Ken Griffin Staar Surgical CO Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$29.97 - $47.42 $3.61 Million - $5.72 Million	120,600 Added 426.15%	148,900 $5.53 Million
Q2 2024 Aug 14, 2024	SELL	$38.07 - $52.25 $3.22 Million - $4.42 Million	-84,600 Reduced 74.93%	28,300 $1.35 Million
Q1 2024 May 15, 2024	BUY	$27.67 - $39.61 $766,459 - $1.1 Million	27,700 Added 32.51%	112,900 $4.32 Million
Q4 2023 Feb 14, 2024	BUY	$30.6 - $43.78 $1.37 Million - $1.97 Million	44,900 Added 111.41%	85,200 $2.66 Million
Q3 2023 Nov 14, 2023	SELL	$39.39 - $58.12 $382,083 - $563,764	-9,700 Reduced 19.4%	40,300 $1.62 Million
Q2 2023 Aug 14, 2023	BUY	$50.45 - $72.82 $257,295 - $371,381	5,100 Added 11.36%	50,000 $2.63 Million
Q1 2023 May 15, 2023	SELL	$51.25 - $79.34 $194,750 - $301,492	-3,800 Reduced 7.8%	44,900 $2.87 Million
Q4 2022 Feb 14, 2023	SELL	$46.82 - $76.2 $8.45 Million - $13.7 Million	-180,400 Reduced 78.74%	48,700 $2.36 Million
Q3 2022 Nov 14, 2022	BUY	$70.55 - $111.58 $10.7 Million - $16.9 Million	151,600 Added 195.61%	229,100 $16.2 Million

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.28B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.